Drug Shortage Report for MYLAN-ENALAPRIL
Report ID | 54237 |
Drug Identification Number | 02300052 |
Brand name | MYLAN-ENALAPRIL |
Common or Proper name | ENALAPRIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ENALAPRIL SODIUM |
Strength(s) | 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BT, 500 BT |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2020-01-23 |
Shortage status | Resolved |
Updated date | 2020-02-20 |
Company comments | Discontinued in ID 106759. Last lot 3049782-1 exp 2019-12-31 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-02-20 | French | Compare |
v5 | 2020-02-20 | English | Compare |
v4 | 2020-02-20 | French | Compare |
v3 | 2020-02-20 | English | Compare |
v2 | 2018-07-04 | French | Compare |
v1 | 2018-07-04 | English | Compare |
Showing 1 to 6 of 6